1969 - SARS-CoV-2 seroprevalence among patients with cancer and healthcare workers from an oncology referral center during the first year of COVID-19 vaccination in Mexico

Saturday, October 22, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

Rodrigo Villaseñor-Echavarri, MD (he/him/his)

MD
Instituto Nacional de Cancerologia
Mexico City, Distrito Federal, Mexico

DD

Daniel De-la-Rosa-Martinez, MD

MD
Instituto Nacional de Cancerologia
Mexico City, Distrito Federal, Mexico
EF

Emmanuel Frias-Jimenez, MSc

Instituto Nacional de Medicina Genomica
Mexico City, Distrito Federal, Mexico
AM

Alexandra Martin-Onraet, MD, MSc

Instituto Nacional de Cancerologia
Mexico City, Distrito Federal, Mexico
ER

Erika Ruiz-Garcia, MD, MSc

Instituto Nacional de Cancerologia
Mexico City, Distrito Federal, Mexico
AC

Alonso Cruz-Cruz, MSc

Instituto Nacional de Medicina Genomica
Mexico City, Distrito Federal, Mexico
LH

Luis Alonso Herrera-Montalvo, PhD

Instituto Nacional de Medicina Genomica
Mexico City, Distrito Federal, Mexico
Diana Vilar-Compte, MD, MSc

Professor
Instituto Nacional de Cancerología
Mexico City, Distrito Federal, Mexico